Claims for Patent: 5,856,138

Summary for Patent: 5,856,138

Title:	Human parathyroid hormone muteins and production thereof
Abstract:	Disclosed are (1) a human parathyroid hormone mutein which comprises at least one modification selected from the group consisting of (i) deletion of 3 to 6 amino acid residues on the N-terminal side in the amino acid sequence of human parathyroid hormones, (ii) substitution of another lipophilic amino acid residue for at least one methionine residue in the amino acid sequence, and (iii) substitution of a cysteine residue for one amino acid residue within the region of amino acid residue Nos. 34 to 47 in the amino acid sequence; (2) a recombinant DNA having a nucleotide sequence coding for the human parathyroid hormone mutein described in (1); (3) a vector containing the recombinant DNA described in (2); (4) a vector in which the recombinant DNA described in (2) is inserted into a region controlled by an E. coli T7 promoter; (5) a transformant which is transformed by the recombinant DNA described in (2); and a process for producing a human parathyroid hormone mutein which comprises cultivating the transformant described in (5) in a culture medium.
Inventor(s):	Fukuda; Tsunehiko (Kyoto, JP)
Assignee:	Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:	08/733,446
Patent Claims:	1. A human parathyroid hormone (1-84) mutein comprising substitution of a cysteine residue for one amino acid residue within the region of amino acid residue number 34 to 47 in the amino acid sequence of human parathyroid hormone (1-84), wherein cleavage of the mutein at the cysteine residue produces an human parathyroid hormone fragment having parathyroid hormone activity. 2. The human parathyroid hormone (1-84) mutein claimed in claim 1, which is human parathyroid hormone (1-84). 3. A recombinant DNA having a nucleotide sequence coding for the human parathyroid hormone (1-84) mutein claimed in claim 1. 4. A vector containing the recombinant DNA claimed in claim 3. 5. A vector in which the recombinant DNA claimed in claim 3 is inserted into a region controlled by an Escherichia coli T7 promoter. 6. A host cell which is transformed by the recombinant DNA claimed in claim 3. 7. A process for producing a human parathyroid hormone (1-84) mutein which comprises cultivating the transformed host cell claimed in claim 6 in a culture medium under conditions suitable for expression of the mutein.

Details for Patent 5,856,138

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2011-08-07